Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

Conditions:   Bowen's Disease;   Superficial Basal Cell Carcinoma Interventions:   Device: full ablative CO2 laser;   Device: fractional ablative CO2 laser;   Drug: MAL;   Device: LED lamp;   Drug: lidocaine hydrochloride 2% with epinephrine Sponsor:   University Hospital, Ghent Recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials